GLP-1 receptor agonists: Are they friends or foes in colorectal cancer?
Research in mice suggests that blocking, rather than activating the GLP-1 receptor may boost the immune response against colorectal cancer…
Tag: Eli Lilly
Eli Lilly attacks weight-loss drug knockoffs as competition intensifies
Eli Lilly unleashed a flurry of lawsuits against wellness centers, medical spas and others the pharmaceutical company accused of illegally…
Eli Lilly Braces for More Out-of-Pocket Payments as Zepbound Obesity Pill Nears Phase III Readout
As Eli Lilly’s highly anticipated obesity medication, Zepbound (tirzepatide), approaches its Phase III clinical trial readout, the pharmaceutical giant is…
Title: ENDO 2024: Ozempic Outperforms Mounjaro in Head-to-Head Weight Loss Trial
At the Endocrine Society’s annual meeting (ENDO 2024), highly anticipated results from a head-to-head trial comparing two popular weight-loss drugs,…
The Weight Loss Drug Boom: New Products Emerge to Meet Soaring Demand
The unprecedented success of weight-loss medications like Wegovy, Ozempic, and Mounjaro has sparked a flurry of activity in the pharmaceutical…
Busting Myths Around Weight Loss Medication
Summary: As the use of weight loss medications like Ozempic and Wegovy continues to rise, so do the misconceptions surrounding…
Weight loss drugs weigh heavy on employer health plans
As the popularity of weight-loss drugs like Ozempic and Wegovy continues to soar, a growing number of employers are considering…
GLP-1 Coverage Often Denied for Teens With Obesity
A recent study has revealed that many teenagers struggling with obesity are being denied insurance coverage for GLP-1 medications, despite…
Kroger to Start Offering GLP-1 Weight Loss Drugs
Kroger, one of the largest grocery retailers in the United States, has announced plans to begin offering popular GLP-1 medications…
It’s Safe to Take GLP-1 Weight Loss Meds Before Surgery: Study
A new review has addressed recent concerns about the safety of taking GLP-1 medications like Ozempic and Wegovy before undergoing…
